1. Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses;CPMP,1996
2. Note for guidance on production and quality control of animal immunoglobulins and immunosera for human use;CPMP,2002
3. Note for guidance on quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin;CPMP,1997
4. Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins;Kempf;Biologicals,2007
5. Guidelines for the production control and regulation of snake antivenoms immunoglobulins,2010